Last update: 11 hours ago

Study predicts HIV infections could rise 10% if CDC testing funds end

HIV & AIDS news

Study predicts HIV infections could rise 10% if CDC testing funds end

Timely HIV diagnosis and treatment are critical to preventing transmission. To help make this happen, the U.S. Centers for Disease Control and Prevention (CDC) provides funding for HIV testing to local health departments ...

11 hours ago

US sexual health report card: High pleasure, low testing, stark gender disparities

A new sexual health survey reveals a mix of progress and persistent gaps. Overall, many Americans report positive experiences—interest in having sex, sexual pleasure, and good communication with partners—yet women and gender-diverse ...

Apr 6, 2026

Switching to integrase inhibitors from protease inhibitors is associated with new diabetes risk in people with HIV

Diabetes mellitus affects more than 10% of people with HIV, and its incidence is rising as the population ages, according to the National Institutes of Health. Antiretroviral therapies that treat HIV by blocking specific ...

Mar 30, 2026

Q&A: How studying two different viruses can lead to new strategies for more potent antiviral treatments

Beyond both being viruses, HIV-1 and SARS-CoV-2 don't seem to have a lot in common. HIV-1 is a retrovirus that integrates with its host's DNA for life and can be passed down from mother to child, while SARS-CoV-2 is contagious ...

Mar 30, 2026

The US is driving a public health emergency of international concern, say researchers

The Trump administration's decision to halt most US foreign aid and development work constitutes a public health emergency of international concern (PHEIC) under international law, argue experts in The BMJ.

Mar 25, 2026

Existing medication can restore HIV-affected immune cells

HIV exhausts the body's immune system by overactivating it, despite effective antiviral treatment. Researchers from Linköping University in Sweden have conducted cell studies showing that an existing medication restores immune ...

Mar 23, 2026

Dual immune response may keep HIV in check without medication

Imagine a game of chess where your opponent's king is in check. It cannot move, but the game is not over—the piece remains on the board. This is how the body might control HIV on its own: The virus would be contained and ...

Mar 23, 2026

Why some people naturally control HIV even after stopping therapy—and how we can leverage that to treat others

For millions of people living with HIV, a daily regimen of medications is a lifelong necessity. If they stop taking the drugs—commonly referred to as antiretroviral therapy—the virus usually rushes back within weeks. But ...

Mar 20, 2026

HPV vaccination protects girls living with HIV in South Africa, study shows

New research shows first population-level evidence globally that a national HPV vaccination program can be highly effective in a high HIV-prevalence setting. In South Africa, where the burden of HIV remains high, women living ...

Mar 18, 2026

Multi-strain probiotic therapy shows promise in preventing bacterial vaginosis recurrence

A global team of experts has identified a promising new approach to prevent recurrence of bacterial vaginosis (BV), a condition that affects millions of women worldwide. In a Phase I randomized clinical trial of women in ...

Mar 18, 2026

HIV prevention expert publishes commentary on game-based learning for youth

A University at Buffalo researcher who studies adolescent HIV prevention in African and diaspora communities was invited to contribute a commentary in the April issue of The Lancet Child & Adolescent Health. Gloria Aidoo-Frimpong's ...

Mar 17, 2026

Twice‑yearly injectable HIV regimen treatment demonstrates strong efficacy and safety in Phase 2 trial

A new study published in The Lancet Microbe reports the first twice-yearly injectable HIV treatment regimen—combining lenacapavir, teropavimab, and zinlirvimab—has achieved high rates of viral suppression and demonstrated ...

Mar 16, 2026

Multi-cytokine scaffold helps CAR-T cells fight cancer and HIV for longer

A research team led by Albert Einstein College of Medicine scientists has developed a new strategy to engineer immune cells that dramatically prolongs their effectiveness after being infused into patients to fight cancer ...

Mar 13, 2026

Uncovering HIV's hidden loop: New finding offers hope for future treatments

For decades, scientists have recognized that human immunodeficiency virus (HIV) is a formidable viral pathogen. After years of probing work and extensive experimentation, a Yale research team has unlocked one of the reasons ...

Mar 13, 2026

People with HIV did not show more severe clinical symptoms during the 2022 mpox outbreak in Spain

People affected by human immunodeficiency virus (HIV), which causes AIDS, did not develop more severe forms of mpox than HIV-negative people during the multiregional outbreak of this disease that occurred in Spain in 2022. ...

Mar 11, 2026

Why HIV prevention is falling short in Kampala's informal settlements

While the rate of HIV in Kampala, Uganda, is more than double the national average, a recent survey of displaced youths in the city found that only about 20% consistently used condoms and just half of the study participants ...

Mar 9, 2026

HIV-seq tool finds active reservoir cells during therapy

For people living with human immunodeficiency virus (HIV), life-saving antiretroviral therapy keeps their HIV-infected immune cells from making new copies of the virus, preventing illness and transmission. Historically, these ...

Mar 7, 2026

Machine-learning immune-system analysis study may hold clues to personalized medicine

How people with compromised immune systems respond to vaccines is an important area of immunological research. A study led by York University has found that not only could machine-learning models accurately pinpoint differences ...

Mar 4, 2026

Q&A: Integrating tobacco treatment in HIV care

Modern HIV treatment is one of medicine's great success stories. With today's therapies, many people living with HIV can expect long, full lives. But as patients age, a new reality has emerged: The biggest threats to their ...

Mar 4, 2026

Nearly 20 states scale back HIV medication programs

A growing number of states are rolling back financial help for HIV medications.

Mar 3, 2026

HIV can develop resistance to blockbuster antiviral lenacapavir—but at a cost to the virus

Long-acting antiviral medications are transforming HIV prevention and care, requiring only minimalistic dosing. But as the use of lenacapavir expands, scientists are probing a critical question: If the virus evolves resistance, ...

Feb 28, 2026 feature

Monthly cabotegravir-rilpivirine injections superior to standard oral ART for HIV with adherence challenges

Monthly injections of long-acting cabotegravir-rilpivirine are superior to standard oral antiretroviral therapy (ART) in persons with human immunodeficiency virus (HIV) and medication adherence challenges, according to a ...

Feb 27, 2026

Single daily pill shows promise as replacement for complex, multi-tablet HIV treatment regimens

A new, daily oral tablet that combines two current HIV treatment medications, bictegravir and lenacapavir (BIC/LEN), could effectively replace more complicated HIV treatment regimens used by people living with HIV who are ...

Feb 25, 2026

US funding freeze linked to HIV care disruptions in 32 countries, study finds

A new study led by researchers from the CUNY Institute for Implementation Science in Population Health (ISPH) finds that the 2025 freeze on U.S. foreign assistance triggered disruptions to HIV services, medications, labs, ...

Feb 25, 2026

Lab-grown reservoir cells aim at HIV's last strongholds

A new study has overcome a long-standing challenge: how to isolate and study elusive HIV-infected cells called authentic reservoir clones (ARCs) that evade the immune system, making the disease difficult to cure. Researchers ...

Feb 24, 2026